Netherlands National Drug Monitor - Research and Documentation ...

Table 2.7a Cannabis use in the general population of a number of EU-15 member states and Norway:
age group 15 to 64 years
Country Year Ever use Recent use Current use
France 2005 31% 9% 5%
Spain 2005/6 29% 11% 9%
Italy 2005 29% 11% 6%
The Netherlands 2005 23% 5% 3%
Austria 2004 20% 8% 4%
Ireland 2006/2007 22% 6% 3%
Norway 2004 16% 5% 2%
Finland 2006 14% 4% 2%
Belgium 2004 13% 5% 3%
Greece 2004 9% 2% 1%
Portugal 2007 12% 4% 2%
A precise comparison between countries is hampered by differences in survey year, measuring methods and
sampling. Percentage of ever users, recent (past year) and current (past month). - = not measured. Source:
EMCDDA
Table 2.7b Cannabis use in the general population of a number of EU- 15 member states and
Canada, the US and Australia: other age groups I
Country Year Age (yrs) Ever use Recent use Current use
Canada 2004 15 + 49% 15% -
United States 2008 12 + 41% 10% 6%
Denmark 2005 16-64 37% 5% 3%
Australia 2007 14+ 34% 9% 5%
U.K. (England & Wales) 2006/2007 16-59 30% 8% 5%
Germany 2006 18 – 64 23% 5% 2%
Italy 2003 15 – 54 22% 7% 5%
Sweden 2006 16 – 64 12% 2% 1%
A precise comparison between countries is hampered by differences in survey year, measuring methods and
sampling. Percentage of ever users, recent (past year) and current (past month).
I. Drug use is relatively low in the youngest (12-15) and oldest age groups (>64). Consumption figures in
studies with respondents younger and/or older than the EMCDDA standard may be lower than figures in
studies that do use the EMCDDA-standard. The opposite is true for studies with a more limited age span.
- = not measured. Sources: CAS, SAMHSA, EMCDDA, AIHW
46 Netherlands National Drug Monitor - NDM Annual Report 2009